Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inter Parfums preclose Q3

This article was originally published in The Rose Sheet

Executive Summary

Firm's 2003 sales will top $177 mil.-$179 mil., representing a 36%-37% gain over 2002, if the dollar remains at current levels, Inter Parfums says in Oct. 9 third quarter sales and earnings preannouncement. Forecast is up from earlier projected sales of $165 mil.-$168 mil. Net income expected to jump 35%-37% to $12.7 mil.-$12.9 mil., company says. Inter Parfums also predicts aggregate third quarter sales will reach $57 mil., up 53% over the prior-year period. Firm attributes improved performance to launches of Burberry Brit, Diane von Furstenberg Beauty (1"The Rose Sheet" June 23, 2003, p. 6 and 2"The Rose Sheet" June 2, 2003, p. 11). Final Q3 results will be reported Nov. 3...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS011581

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel